Dopaminergic activity in depressed smokers: A positron emission tomography study
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Tobacco dependence is highly prevalent in depressed patients. We assessed changes in [11 C]‐raclopride binding potential (BP) using positron emission tomography (PET) before and after the oral administration of d‐amphetamine in healthy controls and unmedicated patients with current depression with and without current tobacco dependence. Over a single study day 2 [11 C]‐raclopride positron emission tomography scans were taken in 38 subjects: at baseline and 2 h following oral d‐amphetamine 30 mg. Twenty controls (9 smokers, 11 nonsmokers) and 18 subjects with current major depressive episode (8 smokers, 10 non‐smokers). Striatal [11 C]‐raclopride binding potential was measured before and after d‐amphetamine administration. Depressed smokers had a lower baseline [11 C]‐raclopride binding potential compared with both control non‐smokers (P < 0.007) and depressed non‐smokers (P < 0.001). There was a main effect of smoking status on amphetamine‐induced change in [11 C]‐raclopride binding potential (P < 0.02), but no main effect of depression. This may be due to a floor effect because of the low BP at baseline. Depressed subjects reported significant increase of positive mood after d‐amphetamine administration compared with controls (depressed smokers vs. control smokers: P < 0.05; depressed non‐smokers vs. controls: P < 0.055). Tobacco dependence appears to decrease d‐amphetamine‐induced changes in [11 C]‐raclopride binding potential as measured by positron emission tomography. Comorbid major depression and tobacco dependence exacerbates this effect, suggesting an altered dopamine system in comorbid patients. Synapse 63:681–689, 2009. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Childress, A.-R., Jayne, M., Ma, Y., & Wong, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1544-06.2006 · Cited by 1,164 · cited 2×
“In summary, chronic cigarette smoking produces a differential response to d-amphetamine between smokers and non-smokers, and baseline [11C]-raclopride displacement was lower in smokers than in controls, supporting the role of chronic smoking altering dopaminergic pathways and consistent with decreased availability of…”
ResultDopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101 · cited 2×
“A large body of literature implicates disturbed DA function in substance use disorders (Di Chiara and Imperato, 1988; Volkow et al., 2004), including smoking - both in animals and humans (Brody et al., 2004; Marenco et al., 2004; Tsukada et al., 2005).”
BackgroundGoldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., & Mayberg, H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.34 · Cited by 1,068
Self-citationDecreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N. (1997) · Nature · doi:10.1038/386830a0 · Cited by 854
Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression
Drevets, W. C. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26027-5 · Cited by 659
Meyer, J. H., Ginovart, N., Boovariwala, A., Sagrati, S., Hussey, D., Garcia, A., Young, T., Praschak-Rieder, N., Wilson, A. A., & Houle, S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1209 · Cited by 585
Self-citationNeuroimaging Abnormalities in the Amygdala in Mood Disorders
DREVETS, W. C. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07098.x · Cited by 544
Leyton, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00366-4 · Cited by 476
Major depression and cigarette smoking: Results of a 21-year longitudinal study
FERGUSSON, D. M., GOODWIN, R. D., & HORWOOD, L. J. (2003) · Psychological Medicine · doi:10.1017/s0033291703008596 · Cited by 374
Predicting smoking cessation and major depression in nicotine-dependent smokers
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.7.1122 · Cited by 293 · cited 2×
“*Correspondence to: Dr. U. Busto, Centre for Addiction and Mental Health, Clinical Neuroscience Section, Russell Street Site, 33 Russell Street, Room 1058, Toronto, Ontario, Canada M5S 2S1.”
BackgroundInfluentialLower dopamine transporter binding potential in striatum during depression
Meyer, J. H., Krüger, S., Wilson, A. A., Christensen, B. K., Goulding, V. S., Schaffer, A., Minifie, C., Houle, S., Hussey, D., & Kennedy, S. H. (2001) · Neuroreport · doi:10.1097/00001756-200112210-00052 · Cited by 269
Self-citationDifferential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase
White, T. L., Justice, A. J. H., & de Wit, H. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00818-3 · Cited by 248 · cited 1×
“There was no correction for possible hormonal differences in the subjects (White et al., 2002) and the study was not age- and gender-matched.”
BackgroundTremblay, L. K., Naranjo, C. A., Cardenas, L., Herrmann, N., & Busto, U. E. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.409 · Cited by 229
Self-citationDopamine D2 receptors in depression measured with single photon emission computed tomography
D'haenen, H. A., & Bossuyt, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91202-5 · Cited by 189 · cited 3×
“Although there is considerable evidence to suggest a role for dopamine in MDD, PET studies in humans have reported no consistent changes in striatal D2 binding (D’Haenen and Bossuyt, 1994; Parsey et al., 2001).”
BackgroundGlobal use of alcohol, drugs and tobacco
ANDERSON, P. (2006) · Drug and Alcohol Review · doi:10.1080/09595230600944446 · Cited by 151
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
Parsey, R. V., Oquendo, M. A., Zea-Ponce, Y., Rodenhiser, J., Kegeles, L. S., Pratap, M., Cooper, T. B., Van Heertum, R., Mann, J. J., & Laruelle, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01089-7 · Cited by 133 · cited 2×
“Although there is considerable evidence to suggest a role for dopamine in MDD, PET studies in humans have reported no consistent changes in striatal D2 binding (D’Haenen and Bossuyt, 1994; Parsey et al., 2001).”
BackgroundVollenweider, F. X., Maguire, R. P., Leenders, K. L., Mathys, K., & Angst, J. (1998) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(98)00033-x · Cited by 83 · cited 2×
“It is slightly higher than that used in some studies (Leyton et al., 2002), but lower than that used in others (Vollenweider et al., 1998).”
BackgroundResultOral D‐amphetamine causes prolonged displacement of [11C]raclopride as measured by PET
Cárdenas, L., Houle, S., Kapur, S., & Busto, U. E. (2004) · Synapse · doi:10.1002/syn.10282 · Cited by 63 · cited 1×
“This dose was selected based on its safety and ability to produce reliable and measurable positive subjective effects (Cardenas et al., 2004; Krogh, 1998).”
BackgroundSelf-citation
Cited by
Clark, L., Stokes, P. R., Wu, K., Michalczuk, R., Benecke, A., Watson, B. J., Egerton, A., Piccini, P., Nutt, D. J., Bowden-Jones, H., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.067 · Cited by 193
“effects were at least not attributable to smoking status (Busto et al., 2009; c.f. Fehr et al., 2008).”
Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity
Trifilieff, P., & Martinez, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.031 · Cited by 171
Visualizing epigenetics: Current advances and advantages in HDAC PET imaging techniques
Wang, C., Schroeder, F. A., & Hooker, J. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.018 · Cited by 48
Dopamine Function in Cigarette Smokers: An [18F]-DOPA PET Study
Bloomfield, M. A., Pepper, F., Egerton, A., Demjaha, A., Tomasi, G., Mouchlianitis, E., Maximen, L., Veronese, M., Turkheimer, F., Selvaraj, S., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.87 · Cited by 48
Nikolaus, S., Mamlins, E., Hautzel, H., & Müller, H.-W. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0037 · Cited by 35
Metadata
- Authors
- Busto, U. E., Redden, L., Mayberg, H., Kapur, S., Houle, S., & Zawertailo, L. A.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2009-04-09
- Volume
- 63
- Issue
- 8
- Pages
- 681-689
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2132412870
- Cited by
- 54
- References
- 20
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.